Review and Update: Oncogenic Osteomalacia-Rickets

References

• Agus ZS. Oncogenic hypophosphatemic osteomalacia. Kidney Int. 1983; 24: 113–123
   PubMed Web of Science ®Google Scholar
• Frame B, Parfitt AM. Osteomalacia: current concepts. Ann Intern Med. 1978; 89: 966–982
   PubMed Web of Science ®Google Scholar
• Mankin HJ. Rickets, osteomalacia, and renal osteodystrophy. J Bone Joint Surg [Am] 1974; 56: 101–128
   Google Scholar
• Stansbury SW. Tumor-associated hypophos-phataemic osteomalacia and rickets. Clin Endocrinol. 1972; 1: 256–266
   Google Scholar
• McCance RA. Osteomalacia with Looser's nodes (Milkman's syndrome) due to a raised resistance to vitamin D acquired about the age of 15 years. Q J Med. 1947; 16: 33–47
   PubMedGoogle Scholar
• Prader A, Illig R, Uehlinger RE, Stalder G. Rachitis infolge knochentumors [Rickets caused by bone tumors]. Helv Pediatr Acta. 1959; 14: 554–565
   PubMedGoogle Scholar
• Dent CE, Friedman M. Hypophosphatemic osteomalacia with complete recovery. Dr Med J. 1964; 1: 1676–1679
   PubMedGoogle Scholar
• Yoshikawa S, Kawabata M, Hatsuyama Y, Hosokawa O, Fujita T. Atypical vitamin-D resistant osteomalacia. J Bone Joint Surg [Am] 1964; 46: 998–1007
   PubMedGoogle Scholar
• Castleman B, McNeely BU. Case records of the Massachusetts General Hospital: case 38-1965. N Engl J Med. 1965; 273: 494–504
   PubMedGoogle Scholar
• Salassa RM, Jowsey J, Arnaud CD. Hypophosphatemic osteomalacia associated with nonendocrine tumors. N Engl J Med. 1970; 282: 65–70
   Google Scholar
• Evans DJ, Azzopardi JG. Distinctive tumours of bone and soft tissue causing acquired vitamin-D-resistant osteomalacia. Lancet 1972; 2: 353–354
   PubMedGoogle Scholar
• Olefsky J, Kempson Ft, Jones H, Reaven G. Tertiary hyperparathyroidism and apparent ‘cure’ of vitamin-D-resistant rickets after removal of an ossifying mesenchymal tumor of the pharynx. N Engl J Med. 1972; 286: 740–745
   PubMedGoogle Scholar
• Pollack JA, Schiller AL, Crawford JD. Rickets and myopathy cured by removal of nonossify-ing fibroma of bone. Pediatrics 1973; 52: 364–371
   PubMedGoogle Scholar
• Moser CR, Fessel WJ. Rheumatic manifestations of hypophosphatemia. Arch Intern Med. 1974; 134: 674–678
   PubMedGoogle Scholar
• Wilhoite DR. Acquired rickets and solitary bone tumor: the question of a causal relationship. Clin Orthop. 1975; 109: 210–211
   Google Scholar
• Linovitz RJ, Resnick D, Keissling P, et al. Tumor-induced osteomalacia and rickets: a surgically curable syndrome. J Bone Joint Surg [Am] 1976; 58: 419–423
   PubMedGoogle Scholar
• Dent CE, Gertner JM. Hypophosphataemic osteomalacia in fibrous dysplasia. Q J Med. 1976; 45: 411–420
   PubMedGoogle Scholar
• Wyman AL, Paradinas FJ, Daly JR. Hypophosphataemic osteomalacia associated with a malignant tumor of the tibia: report of a case. J Clin Pathol. 1977; 30: 328–335
   PubMedGoogle Scholar
• Aschinberg LC, Solomon LM, Zies PM, Justice P, Rosenthal IM. Vitamin-D-resistant rickets associated with epidermal nevus syndrome: demonstration of a phosphaturic substance in the dermal lesions. J Pediatr. 1977; 91: 56–60
   PubMedGoogle Scholar
• Yosikawa S, Nakamura T, Takagi M, Imamura T, Okano K, Satoshi S. Benign osteoblastoma as a cause of osteomalacia. A report of two cases. J Bone Joint Surg [Am] 1977; 59: 279–286
   PubMedGoogle Scholar
• Drezner MK, Feinglos MN. Osteomalacia due to 1,25-dihydroxycholecalciferol deficiency. J Clin Invest. 1977; 60: 1046–1053
   PubMedGoogle Scholar
• Boriani S, Companacci M. Osteoblastoma associated with osteomalacia (presentation of a case and review of the literature). Ital J Orthop Traumatol. 1978; 4: 379–382
   PubMedGoogle Scholar
• Fukumoto Y, Seiichiro T, Keiko T, et al. Tumor-induced vitamin-D-resistant hypophosphatemia osteomalacia associated with proximal tubular dysfunction and 1,25-dihydroxyvitamin-D deficiency. J Clin Endocrinol Metab. 1979; 49: 873–878
   PubMedGoogle Scholar
• Turner ML, Dalinka MK. Osteomalacia: uncommon causes. Am J Radiol. 1979; 133: 539–540
   Google Scholar
• Sweet RA, Males JL, Hamstra AJ, DeLuca HF. Vitamin D metabolite levels in oncogenic osteomalacia. Ann Intern Med. 1980; 93: 279–280
   PubMed Web of Science ®Google Scholar
• Camus JP, Crouzet J, Prier A, Grillemant S, Ulmann A, Koeger AC. Osteomalacies hypophophoremiques queries par I'ablation de tumeurs benignes dutissu conjontiff: etude de trois observations avec dosages pre- et post-operatoires des metabolites de la vitamine D [Hypophosphatemic osteomalacia correlated with the ablation of associated benign connective-tissue tumors: report of 3 cases with pre- and post-operative treatment with Vitamin D metabolites]. Ann Med Intern (Paris) 1980; 131: 422–426
   PubMedGoogle Scholar
• Parker MS, Klein I, Haussier MR, Mintz DH. Tumor-induced osteomalacia. Evidence of surgically correctable alteration in vitamin D metabolism. JAMA 1981; 245: 492–493
   PubMedGoogle Scholar
• Nitzan DW, Marmary Y, Azax B. Mandibular tumor-induced muscular weakness and osteomalacia. Oral Surg Oral Med Oral Pathol. 1981; 52: 253–256
   PubMedGoogle Scholar
• Asnes RS, Berdon WE, Bassett A. Hypophosphatemic rickets in an adolescent cured by excision of a nonossifying fibroma. Clin Pediatr. 1981; 20: 646–648
   PubMedGoogle Scholar
• Nomura G, Koshino Y, Morimoto H, Kida H, Nomura S, Tamai K. Vitamin D resistant hypophosphatemic osteomalacia associated with osteosarcoma of the manible: report of a case. Jpn J Med. 1981; 21: 35–39
   Google Scholar
• Robertson A. Case of the winter season. Semin Roentgenol 1983; 18: 5–6
   PubMedGoogle Scholar
• Smith WS, Linsey M, Bernstein L, Yamauchi H. Nasopharyngeal angiofibroma presenting as adult osteomalacia: case report and review of the literature. Laryngoscope 1983; 93: 1328–1331
   PubMedGoogle Scholar
• Weidner N, Bar RS, Weiss D, Strottmann P. Neoplastic pathology of oncogenic osteomalacia-rickets. Cancer 1985; 55: 1691–1695
   PubMed Web of Science ®Google Scholar
• Morita M. A case of adult onset vitamin D resistant osteomalacia associated with soft tissue tumor. Kotsudaisha. 1976; 9: 286–290
   Google Scholar
• Lejeune E, Bouvier M, Meunier P, et al. L'os-teomalacie des tumeurs mesenchymateuses [Osteomalacia from mesenchymal tumors]. Rev Rhum Mai Osteoartic. 1979; 46: 187–193
   PubMedGoogle Scholar
• Crouzet J, Camus JP, Gatti JM, Descamps H, Beraneck L. Osteomalacie hypophosphoremique et hemangiopericytome de la voute du crane [Hypophophatemic osteomalacia associated with hemangiopericytoma of the cranial vault]. Rev Rhum Mai Osteoartic. 1980; 47: 523–529
   PubMedGoogle Scholar
• Firth RG, Grant CS, Riggs BL. Development of hypercalcemic hyperparathyroidism after long-term phosphate supplementation in hypophosphatemic osteomalacia. Report of two cases. Am J Med. 1985; 78: 669–673
   PubMedGoogle Scholar
• Cotton GE, Van Puffelen P. Hypophosphatemic osteomalacia secondary to neoplasia. J Bone Joint Surg Am. 1986; 68: 129–133
   PubMedGoogle Scholar
• Gitelis S, Ryan WG, Rosenberg AG, Templeton AC. Adult-onset hypophosphatemic osteomalacia secondary to neoplasm. J Bone Joint Surg Am. 1986; 68: 134–138
   PubMedGoogle Scholar
• Weidner N, Santa Cruz D. Phosphaturic mesenchymal tumors, a polymorphous group causing osteomalacia-rickets. Cancer 1987; 59: 1442–1454
   PubMed Web of Science ®Google Scholar
• Nuova MA, Dorfman HD, Sun CCJ, Chalew SA. Tumor-induced osteomalacia and rickets. Am J Surg Pathol. 1989; 13: 588–599
   PubMedGoogle Scholar
• Scully RE. Case records of the Massachusetts General Hospital. Case 52-1989. N Engl J Med. 1989; 321: 1812–1821
   PubMedGoogle Scholar
• Hernberg CA, Edgren W. Looser-Milkman's syndrome with neurofibromatosis Recklinghausen and general decalcification of the skeleton. Acta Med Scand. 1949; 136: 26–33
   PubMedGoogle Scholar
• Salville PD, Nassim JR, Stevenson SH, Mulligan L, Margaret C. Osteomalacia in Von Recklinghausen's neurofibromatosis: metabolic study of a case. Br Med J. 1955; 1: 1311–1313
   PubMedGoogle Scholar
• Hauge BD. Vitamin D resistant osteomalacia. Acta Med Scand. 1956; 153: 271–282
   PubMedGoogle Scholar
• Mittal MM, Gupta MC, Sharma ML. Osteomalacia in neurofibromatosis (report of two cases). J Assoc Physicians India 1971; 19: 823–825
   PubMedGoogle Scholar
• Hosking DJ, Chamberlain MJ, Shortland-Webb WR. Osteomalacia and carcinoma of the prostate with major redistribution of skeletal calcium. Br J Radiol. 1975; 48: 451–456
   PubMedGoogle Scholar
• Renton P, Shaw DG. Hypophosphatemic osteomalacia secondary to vascular tumors of bone and soft tissue. Skeletal Radiol. 1976; 1: 21–24
   Google Scholar
• Moncrieff MW, Brenton DP, Arthur LJH. Case of tumour rickets. Arch Dis Child. 1978; 53: 740–745
   PubMedGoogle Scholar
• Daniels RA, Weisenfield I. Tumorous phosphaturic osteomalacia: report of a case associated with multiple hemangiomas of bone. Am J Med. 1979; 67: 155–159
   PubMedGoogle Scholar
• Lyles KW, Berry WR, Haussler M, Harrelson JM, Drezner MK. Hypophosphatemic osteomalacia: association with prostate carcinoma. Ann Intern Med. 1980; 93: 275–278
   PubMed Web of Science ®Google Scholar
• Retnam VJ, Rangnekar DM, Bhandarkar SD. Neurofibromatosis with hypophosphatemic osteomalacia (Von Recklinghausen-Hernberg-Edgren-Swann syndrome) (a case report). J Assoc Physicians India 1980; 28: 319–322
   PubMedGoogle Scholar
• Chacko V, Joseph B. Osteomalacia associated with hemangiopericytoma. J Indian Med Assoc. 1981; 76: 173–175
   PubMedGoogle Scholar
• Cramer CF, Aikawa M, Cebelin M. Neurosecretory granules in small cell invasive carcinoma of the bladder. Cancer 1981; 47: 724–730
   PubMed Web of Science ®Google Scholar
• Kabadi UM. Osteomalacia associated with prostatic cancer and osteoblastic metastases. Urology 1983; 21: 65–67
   PubMedGoogle Scholar
• Charhon SA, Chapuy MC, Delvin EE, Valentin-Opran A, Edouard CM, Meunier PJ. Histomorphometric analysis of sclerotic bone metastases from prostate carcinoma with special reference to osteomalacia. Cancer 1983; 51: 918–924
   PubMed Web of Science ®Google Scholar
• Taylor HC, Fallon MD, Velasco ME. Oncogenic osteomalacia and inappropriate antidiuretic hormone secretion due to oat-cell carcinoma. Ann Intern Med. 1984; 101: 786–790
   PubMedGoogle Scholar
• Ryan EA, Reiss E. Oncogenous osteomalacia. Review of the world's literature of 42 cases and report of two new cases. Am J Med. 1984; 77: 501–512
   PubMedGoogle Scholar
• Nortman DR, Coburn JW, Brautbar N, . Treatment of mesenchymal tumor associated osteomalacia (MTAO) with 1,25(OH)2D3: report of a case. Vitamin D, Basic Research and Its Clinical Application, AW Norman, K Schaefer, DV Herrath, et al. De Gruyter, Berlin 1979; 1167–1171
   Google Scholar
• Dent DE, Stamp TCB. Hypophosphatemic osteomalacia presenting in adults. Q J Med. 1971; 40: 303–329
   PubMedGoogle Scholar
• Weiss D, Bar RS, Weidner N, Werner M, Lee F. Oncogenic osteomalacia: strange tumors in strange places. Postgrad Med J. 1985; 61: 349–353
   PubMedGoogle Scholar
• Drezner MK, Lobaugh B, Lyles KW, Carey DE, Paulson DF, Harrelson JM. The pathogenesis and treatment of tumor-induced osteomalacia. Vitamin D, Chemical, Biochemical and Clinical Endocrinology of Calcium Metabolism, AW Norman, K Shaefer, DV Herrath, et al. De Gruyter, Berlin 1982; 949–954
   Google Scholar
• Lau K, Stom MC, Goldberg M, et al. Evidence for a humoral phosphaturic factor in oncogenic hypophosphatemic osteomalacia. Clin Res. 1979; 27: 421 A, Abstract
   Google Scholar
• Popovtzer MM. Tumor-induced hypophosphatemic osteomalacia (TUO): evidence for a phosphaturic cyclic AMP-independent action of tumor extract. Clin Res. 1981; 29: 418A, Abstract
   Google Scholar
• Lyles KW, Lobaugh B, Paulsen DF, Drezner MK. Heterotransplantation of prostate cancer from an affected patient creates an animal model for tumor induced osteomalacia in the athymic nude mouse. Calcif Tiss Int. 1982; 34: S33, Abstract
   Google Scholar
• Miyauchi A, Fukase M, Tsutsumi M, Fugita T. Hemangiopericytoma-induced osteomalacia: tumor transplantation in nude mice causes hypophosphatemia and tumor extracts inhibit renal 25-hydroxyvitamin D 1-hydroxylase activity. J Clin Endocrinol Metab. 1988; 67: 46–53
   PubMedGoogle Scholar
• Mirra JM. Bone Tumors, Diagnosis and Treatment. Lippincott, Philadelphia 1980; 500
   Google Scholar
• Malone JD, Teitelbaum GL, Griffin RM, Senior RM, Kahn AJ. Recruitment of osteoclast precursors by purified bone matrix constituents. J Cell Biol. 1982; 92: 227–231
   PubMed Web of Science ®Google Scholar
• Fischman DA, Hay ED. Origin of osteoclasts from mononuclear leukocytes in regenerating newt limbs. Anat Rec. 1962; 143: 329–334
   PubMedGoogle Scholar
• Holtrop ME, King GJ. The ultrastructure of the osteoclast and its functional implications. Clin Orthop. 1977; 123: 177–196
   Google Scholar
• Bonucci E. New knowledge of the origin, function, and fate of osteoclasts. Clin Orthop. 1981; 158: 252–269
   PubMedGoogle Scholar
• Thompson ER, Baylink DJ, Wergedal JE. Increases in number and size of osteoclasts in response to calcium or phosphorus deficiency in the rat. Endocrinology 1975; 97: 283–293
   PubMedGoogle Scholar
• Tieder M, Modal D, Samuel R, et al. Hereditary hypophosphatemic rickets with hypercalciuria. N EnglJ Med. 1985; 312: 611–618
   PubMedGoogle Scholar
• Cameron DG, Warner HA, Szabo AJ. Chronic diarrhea in an adult with hypokalemic nephropathy and osteomalacia due to a functioning ganglioneuroblastoma. Am J Med Sci. 1967; 253: 417–424
   PubMedGoogle Scholar
• Lewis JH, Clement S. Zollinger-Ellison syndrome presenting with osteomalacia. Va Med. 1981; 108: 619–621
   PubMedGoogle Scholar
• Palmucci L, Bertolotto A, Doriguzzi C, Mongini T, Coda R. Osteomalacia myopathy in a case of diffuse nodular lipomatosis of the small bowel. Acta Neurol (Belg) 1982; 82: 65–71
   PubMedGoogle Scholar
• Naide W, Matz R, Spear PW. Cholangiocar-cinoma causing hypercalcemia and hypophosphatemia without skeletal metastases (pseudohypoparathyroidism). Am J Dig Dis. 1968; 13: 705–708
   PubMedGoogle Scholar
• Goldman JW, Becker FO. Ectopic parathyroid hormone syndrome: occurrence in a case of undifferentiated lymphoma with bone marrow involvement. Arch Intern Med. 1978; 138: 1290–1291
   PubMedGoogle Scholar
• Hirano T, Tsuchiyama H, Yanagawa M. An autopsy case of cholangiocarcinoma with hypercalcemia. Acta Pathol Jpn. 1978; 28: 465–469
   PubMedGoogle Scholar
• Sztern M, Barkan A, Rakowsky E, Shainkin-Kestenbaum R, Raphael M, Blum I. Hypercalcemia in carcinoma of the breast without evidence of bone destruction: beneficial effect of hormonal therapy. Cancer 1981; 48: 2383–2385
   PubMedGoogle Scholar
• Zidar BL, Shadduck RK, Winkelstein A, Zeigler Z, Hawker CO. Acute myeloblasts leukemia and hypercalcemia: a case of probable ectopic parathyroid hormone production. N Engl J Med. 1976; 295: 692–694
   PubMed Web of Science ®Google Scholar
• Aderk D, Shoenfield Y, Santo M, et al. Life threatening hypophosphatemia in a patient with acute myelogenous leukemia. Acta Haematol. 1980; 64: 117–119
   PubMedGoogle Scholar
• Zamkoff KW, Kirshner JJ. Marked hypophosphatemia associated with acute myelomonocytic leukemia: indirect evidence of phosphorus uptake by leukemic cells. Arch Intern Med. 1980; 140: 1523–1524
   PubMedGoogle Scholar
• Matzner Y, Prococimer M, Polliack A, Rubinger D, Popovtzer M. Hypophosphatemia in a patient with lymphoma in leukemic phase. Arch Intern Med. 1981; 141: 805–806
   PubMedGoogle Scholar
• Sariban E, Magrath IT. Hypophosphatemia in Burkitt's lymphoma. Arch Intern Med. 1981; 142: 418
   Google Scholar
• Weiss D, Bar RS, Weidner N. Oncogenic osteomalacia. Ann Intern Med. 1985; 102: 557, Letter
   PubMedGoogle Scholar